Pharmacology III Exam III

Steroids MOA

Prevent T-cell activation by blocking cytokine production

Steroid Adverse Effects

Cushing's syndrome, osteoperosis, myopathy, cataracts, glucose intolerance, hypercholesterol

Azothioprine MOA

Disrupts purine incorporation into DNA, prevents proliferation of T-cells

Azothioprine Adverse Effects

Hematological effects, infections, pancreatitis, cholestatic jaundice, heoatitis, interstitial pneumonitis, increase levels with allopurinaol causing increasd neutropenia

Mycophenolate mofentil MOA

Inhibit inosine monophosphate dehydrogenase in guanine synthesis, inhibits DNA synthesis in T and B cells

Mycophenolate Mofentil Adverse Effects

N/V/D - direct GI toxicity, infections, sepsis, leukopenia, lymphoma

Alprostadil

PGE1 analog, erectile dysfunction, maintain ductus arteriosus

Misoprostol

PGE1 analog, GI cytoprotection, abortifacient

Carboprost

PGF2a analog, postpartum bleeding, abortifacient

Dinoprostone

PGE2, abortifacient, cervial preparation

Lubiprostone

PGE1 analog, activates Cl channels to increas fluid secretion into GI, treatment of chronic idiopathic constipation and IBS-constipation

Epoprostenol

PGI2 analog, dilates pulmonary arteries, pulmonary hypertension

Treprostinil

PGI2 analog, dilates pulmonary arteries in pulmonary hypertension

Bimatoprost, Latanoprost, Travoprost

PGF2a analog, increases aquesous humor outflow, open angle glaucoma

Montelukast

LTD4 leukotriene antagonist

Zarfirlukast

leukotriene antagonist, inhibits CYP2C19, 3A4

Zileuton

5-lipoxygenase inhibitor, flu-like syndrome, drowsiness, hepatic enzyme elevation, inhibits CYP1A2, 3A4

CD4+

T-helper cells

CD8+

Cytotoxic T cells

Innate or natural immunity

receptor mediated, no priming, low affinity

Adaptive or learned immunity

antigen specific, priming needed, very high affinity

B lymphocytes

Hummoral immunity, mature in lympohid tissue, slow, responsible for autoimmune, suppress bone marrow to decrease actions, activated by cytokines

T lymphocytes

cellular immunity, must pass through thymus, quick

Antigen presenting cells

dendritic cells, macrophages, B cells

MHC class 1

on all nucleated cells, CD8+ cells

MHC class 2

on B cells, APC, CD4+ cells

Hyperacute rejection

activationof complement, within minutes

Accelerated acute rejection

both cellular and humoral immunity, within 1-4 days

Acute rejection

90% T-cell mediated, 10% humoral mediated, symptoms due to cytokine release

Antiproliferative agents

Azathioprin, Mycophenolate mofetil

Immunoglobins

anti-lymphocyte antibodies

Calcineurin inhibitors

cyclosporin, tacrolimus

IL-2 receptor antagonists

Basiliximab, Daclizumab

mTOR (Target of Rapamycin) inhibitors

Sirolimus

ATGAM

horse, binds peripheral T-cells, rejection prophylaxis and early rejection

Thymoglobulin

Rabbit, depletes circulating T-cells, rejection prophylaxis and early rejection

Muromonab (OKT-3)

mouse, inhibits transduction of antigen recognition, causes internalization of T-cell receptors, acute rejection, first dose response

Basiliximab

mouse, antibody against IL-2 CD25 receptor, prevents activated T-cell killing, prophylaxis and acute rejection

Daclizumab

humanized, antibody against IL-2 CD25 receptor, prevents activated T-cell killing, prophylaxis and acute rejection

Cyclosporin

binds cyclophilin, inhibits calcineurin, prevents NF-AT from stimulating IL-2 transcription

Cyclosporin adverse effects

renal dysfunction, diabetogenic, hyperglycemia, hirsutism

Tacrolimus

Binds FKBP-12 to inhibit calcineurin, prevents NF-AT activating IL-2 transcription, maintenance and rescue

Tacrolimus Adverse Effects

hyperglycemia (more), nephrotoxicity, more disorientation, alopecia

Sirolimus

binds FKBP-12 and inhibits mTOR, acute rejection, prophylaxis, impaired wound healing

Everolimus

similar to sirolimus

Amnesia

hippocampus

Immobiliry

thalamus

Analgesia

pain pathways

Unconsciousness

RAS

Clonidine

decrease NE in the descending pathway - can lower doses of anesthetics

Neostigmine and atropine

used to reverse blockade after surgery

Nitrous Oxide

works on NMDA and K+ receptors, low MAC, fast equilibrium, causes sedation and analgesia, least incidence of malignant hyperthermia, interacts with Vit. B12

Halothane

low MAC, high blood:gas coefficient, CYP2E1 (alcoholics), used in children

Sevoflurane

Lower MAC than halothane, used in children, not irritating, bronchodilator

Enflurane

muscle relaxation, pungent odor, faster induction, little arrhythmias, high conc. causes CNS excitation and seizures

Isoflurane

unconsciousness and muscle relaxation, little effect on CO or arrhythmias, most widely used

Desflurane

Unconsciousness and some muscle relaxation, used for maintenance, 99% eliminated unchanged, irritating to respiratory tract

Xenon

no effect on BP, respiration, CO, no liver or renal toxicity

Dantrolene

blocks Ca release from RYR1 in malignant hyperthermia

Thiopental, Methohexital

used for induction, no analgesia, metabolized by liver, good for head injury, reduces BP and CO

Propofol

little accumulation, less bronchospasm, anti-emetic, hypotension, pain at injection site

Ketamine

not complete unconsciousness, analgesic, reduced senses, immobility, amnesia, increases BP and CBF, less respiratory depression, bronchodilation, unpleasant recovery

Etomidate

little effect on BP or CO, best for coronary disease, cardiomyopathy, CVD, N/V

benzodiazepines

anxiolysis, sedation, amnesia

Dexmetetomidine

analgesic, alpha-2 autoreceptor

pKa >> pH

mostly charge form

pKa < pH

mostly uncharge form (better loacl analgesia)

Cocaine

low potency, short duration of action

Procaine

low potency, short duration of action, not topically effective, dentistry

Benzocaine

too much can cause methemoglobinemea (dose not bind oxygen)

Lidocaine

CYP1A2,insensitivity in ADHD

Etidocaine

lasts longer than lidocaine, obstetrical procedures

Bupivavaine, merpivacine, ropivacane

obststrical procedures, more cardiac complications (depression)

Prilocaine

immediate potency, dentistry, low cardiac, used in intravenouse regional anestheasia, toxic metabolit - methemoglobinemia

Interferon

activates NK cells, upregulates Th1 cells and macrophages, flu-like syndrome

Interferon a-2-a

anticancer, hepatitis C, flu, depression, hpotension, arrhythmia

Interferon a2b

hepatitis B, flu, depression, hpotension, arrhythmia

Interferon b-1a, b-1-b

relaapsing MS, flu

Interferon gamma-1b

activates phagocytosis, increases oxygen radicals, flu, GI distress, weight loss, depression

Stem Cell Growth Factor (Stemgen)

stimulate blood progenitor cells for transplant, increases release from marrow

Sargramostim (CSF)

enhances maturation of neutrophils, platelets, macrophages, eosinophils, RBC, monocytes, stimulate bone marrow, neutropenia, aplastic anemia

Filgrastim (CSF)

glycoprotein, not glycosylated, stimulates proliferation, stimulate WBC, neutropenia and decrease infections after chemotherapy

Pegfilgrastim

Pegylated, increase duration of action

Interleukin-11

increase megakaryocyte maturation, chemotherapy induced thrombocytopenia

Thrombopoietin

increases megakaryocytes

Eltrombopag

non-peptide thrombopoietin agonist, increase platelets, hepatotoxic

Romiplostim

fusion protein linked to two IgI that acts as TPO agonist, bone marrow fibrosis

Plerixafor

CXCR4 receptor antagonist, increase CD34+ stem cell in blood, teratogenic

Erythropoietin

enhances survival, maturation, and proliferation of RBC, used in anemia, use lowest dose, increased cancer?